![The MX908 detects the possibility of presence of fentanyl in a drug sample tested at AHOPE.](https://www.rizema.org/wp-content/uploads/2018/10/MX908-WBUR-harm-reduction.jpg)
The MX908 detects the possibility of presence of fentanyl in a drug sample tested at AHOPE. (Jesse Costa/WBUR)
Enabling Health: Enhancing Harm Reductions Services in Massachusetts
RIZE makes harm reduction a priority and invests over $1m in six organizations that are employing innovative practices to keep people safe and save lives.